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of Internal Medicine,

INTRODUCTION
• Multisystem Inflammatory Syndrome (MIS) is a severe inflammatory
complication of SARS-CoV-2 infection that was initially described in children
and adolescents. There have been several case reports describing a similar
syndrome in adults, referred to as MIS in adults (MIS-A).
• A 39-year-old woman with a past medical history of hypertension and
obesity presented to the emergency department with complaints of
weakness, syncope, diarrhea, and oliguria for the past two days.
• She was admitted to the ICU for management of shock and acute renal
failure.

CASE DESCRIPTION

Vital signs: 96.4F, 96/69 mm Hg, 98 bpm, 19 breaths/minute, SPO2 97% on
room air.
Physical Exam: Non-toxic appearing, no acute distress, dry mucous
membranes. Otherwise, her exam is unremarkable.
DIAGNOSTIC WORK UP
Labwork: leukocytosis, acute kidney injury, lactic acidosis, metabolic acidosis,
and elevated creatinine kinase, ferritin, D-dimer, CRP, and interleukin-6.
Microbiology: Blood and urine cultures were negative. SARS-CoV-2 PCR was
positive. SARS-CoV-2 antibody testing was negative.
Imaging: Echocardiogram showed hyperdynamic left ventricle and moderate
left ventricular hypertrophy, but was otherwise normal. CT scan of the chest,
abdomen, and pelvis was unremarkable.

HOSPITAL COURSE

• Treated with IV fluids, multiple vasopressors, stress dose steroids, and
broad-spectrum antibiotics due to concern for septic shock.
• Intubated due to severe metabolic acidosis and impending respiratory
failure.
• Started on continuous renal replacement therapy due to worsening acute
renal failure
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• Developed atrial fibrillation with rapid ventricular response that was
refractory to two cardioversions.
• Her COVID test returned positive. This along with her clinical picture of
multi-organ involvement, severe inflammation with relative lack of
respiratory disease raised suspicion for MIS-A. She was treated with pulse
dose corticosteroids, IVIG, and tocilizumab.
• She developed acute ischemia of the right hand due to a right radial
thrombus.
• Found to have new anisocoria with decreased responsiveness. MRI of the
head was negative for a stroke.
• Unfortunately, on day 4 the patient suffered from cardiac arrest, which was
unable to be reversed.

DISCUSSION

• Per the Center for Disease Control (CDC), MIS-A is diagnosed by the
following criteria:
1.Hospital admission in patients 21 and older
2.A previous or current positive COVID-19 test during hospital admission or
in the last 12 weeks
3.Severe dysfunction of at least one non-lung organ system (eg, low blood
pressure, shock, cardiac abnormalities, arterial or venous blood clots,
thromboembolism, liver damage)
4.Test results indicating severe inflammation (eg, elevated C-reactive
protein, ferritin, D-dimer, interleukin-6)
5.The absence of severe respiratory disease
• Potential pathways mediating this hyperinflammatory response include
direct viral tissue damage, endothelial damage and thromboinflammation,
dysregulation of immune response, and dysregulation of the RAAS pathway.
• Patients with MIS-A may not have a positive SARS-CoV-2 PCR or antigen test
results. Thus, antibody testing may be needed to confirm prior SARS-CoV-2
infection.
• Of the few case reports of MIS-A, patients have been treated with IVIG,
corticosteroids, and tocilizumab.
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CT scan of the chest which demonstrated relatively clear lungs.

CONCLUSION

• MIS-A is a severe illness requiring hospitalization in adults with COVID-19
infection that is characterized by extrapulmonary organ(s) dysfunction with
lab evidence of inflammation and an absence of severe respiratory disease.
• MIS-A has a heterogenous presentation, often characterized by severe
multi-organ inflammation requiring multidisciplinary care.
• More research is needed to elucidate the pathogenesis and management of
this rare and potentially fatal disease.
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